Search by Drug Name or NDC
NDC 71879-0001-01 Dexycu 517 ug/.005mL Details
Dexycu 517 ug/.005mL
Dexycu is a INTRAOCULAR INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EyePoint Pharmaceuticals US, Inc. The primary component is DEXAMETHASONE.
MedlinePlus Drug Summary
Dexamethasone injection is used to treat severe allergic reactions. It is used in the management of certain types of edema (fluid retention and swelling; excess fluid held in body tissues,) gastrointestinal disease, and certain types of arthritis. Dexamethasone injection is also used for diagnostic testing. Dexamethasone injection is also used to treat certain conditions that affect the blood, skin, eyes, thyroid, kidneys, lungs, and nervous system. It is sometimes used in combination with other medications to treat symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning) and in the management of certain types of shock. Dexamethasone injection is in a class of medications called corticosteroids. It works to treat people with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It also works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.
Related Packages: 71879-0001-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dexamethasone Injection
Product Information
NDC | 71879-0001 |
---|---|
Product ID | 71879-001_cb8f6417-27b3-441b-81b8-6b3a1ee87365 |
Associated GPIs | 86300010001860 |
GCN Sequence Number | 078417 |
GCN Sequence Number Description | dexamethasone/PF VIAL 9 % INTRAOCULR |
HIC3 | Q6P |
HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
GCN | 44741 |
HICL Sequence Number | 044921 |
HICL Sequence Number Description | DEXAMETHASONE/PF |
Brand/Generic | Brand |
Proprietary Name | Dexycu |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dexamethasone |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SUSPENSION |
Route | INTRAOCULAR |
Active Ingredient Strength | 517 |
Active Ingredient Units | ug/.005mL |
Substance Name | DEXAMETHASONE |
Labeler Name | EyePoint Pharmaceuticals US, Inc |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA208912 |
Listing Certified Through | 2024-12-31 |
Package
NDC 71879-0001-01 (71879000101)
NDC Package Code | 71879-001-01 |
---|---|
Billing NDC | 71879000101 |
Package | 1 VIAL, GLASS in 1 CARTON (71879-001-01) / .5 mL in 1 VIAL, GLASS |
Marketing Start Date | 2018-05-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |